View in EDS HTML Full Text PDF Full Text

Inflammation and limited adaptive immunity predict worse outcomes on immunotherapy in head and neck cancer.

Saved in:
Bibliographic Details
Title: Inflammation and limited adaptive immunity predict worse outcomes on immunotherapy in head and neck cancer.
Authors: Paschold L; Department of Internal Medicine IV, Oncology/Hematology, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany., Schultheiss C; Division of Medical Oncology, University Hospital Basel, Basel, Switzerland.; Laboratory of Translational Immuno-Oncology, Department of Biomedicine, University and University Hospital Basel, Basel, Switzerland., Schmidt-Barbo P; Division of Medical Oncology, University Hospital Basel, Basel, Switzerland.; Laboratory of Translational Immuno-Oncology, Department of Biomedicine, University and University Hospital Basel, Basel, Switzerland.; Collaborative Research Institute Intelligent Oncology (CRIION), Freiburg, Germany., Klinghammer K; Department of Hematology and Oncology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Hahn D; Department of Hematology, Oncology, Stem-Cell Transplantation and Palliative Care, Klinikum Stuttgart, Stuttgart, Germany., Tometten M; Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, RWTH Aachen University, Aachen, Germany., Schafhausen P; Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Blaurock M; Department of Otorhinolaryngology, Head and Neck Surgery, University Medicine Greifswald, Greifswald, Germany., Brandt A; Division of Medical Oncology, University Hospital Basel, Basel, Switzerland., Westgaard I; Ultimovacs, Oslo, Norway., Kowoll S; Koordinierungszentrum für Klinische Studien Halle (KKS), Medical Faculty, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany., Stein A; Hematology-Oncology Practice Eppendorf (HOPE), Hamburg, Germany., Hinke A; Clinical Cancer Research Consulting (CCRC), Düsseldorf, Germany., Binder M; Division of Medical Oncology, University Hospital Basel, Basel, Switzerland. mascha.binder@unibas.ch.; Laboratory of Translational Immuno-Oncology, Department of Biomedicine, University and University Hospital Basel, Basel, Switzerland. mascha.binder@unibas.ch.; Collaborative Research Institute Intelligent Oncology (CRIION), Freiburg, Germany. mascha.binder@unibas.ch.
Source: NPJ precision oncology [NPJ Precis Oncol] 2025 Aug 05; Vol. 9 (1), pp. 272. Date of Electronic Publication: 2025 Aug 05.
Publication Type: Journal Article
Journal Info: Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40764401
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Inflammation and limited adaptive immunity predict worse outcomes on immunotherapy in head and neck cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Paschold+L%22">Paschold L</searchLink>; Department of Internal Medicine IV, Oncology/Hematology, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.<br /><searchLink fieldCode="AU" term="%22Schultheiss+C%22">Schultheiss C</searchLink>; Division of Medical Oncology, University Hospital Basel, Basel, Switzerland.; Laboratory of Translational Immuno-Oncology, Department of Biomedicine, University and University Hospital Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Schmidt-Barbo+P%22">Schmidt-Barbo P</searchLink>; Division of Medical Oncology, University Hospital Basel, Basel, Switzerland.; Laboratory of Translational Immuno-Oncology, Department of Biomedicine, University and University Hospital Basel, Basel, Switzerland.; Collaborative Research Institute Intelligent Oncology (CRIION), Freiburg, Germany.<br /><searchLink fieldCode="AU" term="%22Klinghammer+K%22">Klinghammer K</searchLink>; Department of Hematology and Oncology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Hahn+D%22">Hahn D</searchLink>; Department of Hematology, Oncology, Stem-Cell Transplantation and Palliative Care, Klinikum Stuttgart, Stuttgart, Germany.<br /><searchLink fieldCode="AU" term="%22Tometten+M%22">Tometten M</searchLink>; Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, RWTH Aachen University, Aachen, Germany.<br /><searchLink fieldCode="AU" term="%22Schafhausen+P%22">Schafhausen P</searchLink>; Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Blaurock+M%22">Blaurock M</searchLink>; Department of Otorhinolaryngology, Head and Neck Surgery, University Medicine Greifswald, Greifswald, Germany.<br /><searchLink fieldCode="AU" term="%22Brandt+A%22">Brandt A</searchLink>; Division of Medical Oncology, University Hospital Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Westgaard+I%22">Westgaard I</searchLink>; Ultimovacs, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Kowoll+S%22">Kowoll S</searchLink>; Koordinierungszentrum für Klinische Studien Halle (KKS), Medical Faculty, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.<br /><searchLink fieldCode="AU" term="%22Stein+A%22">Stein A</searchLink>; Hematology-Oncology Practice Eppendorf (HOPE), Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Hinke+A%22">Hinke A</searchLink>; Clinical Cancer Research Consulting (CCRC), Düsseldorf, Germany.<br /><searchLink fieldCode="AU" term="%22Binder+M%22">Binder M</searchLink>; Division of Medical Oncology, University Hospital Basel, Basel, Switzerland. mascha.binder@unibas.ch.; Laboratory of Translational Immuno-Oncology, Department of Biomedicine, University and University Hospital Basel, Basel, Switzerland. mascha.binder@unibas.ch.; Collaborative Research Institute Intelligent Oncology (CRIION), Freiburg, Germany. mascha.binder@unibas.ch.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101708166%22">NPJ precision oncology</searchLink> [NPJ Precis Oncol] 2025 Aug 05; Vol. 9 (1), pp. 272. <i>Date of Electronic Publication: </i>2025 Aug 05.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Nature%22">Springer Nature </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101708166 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2397-768X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222397768X%22">2397768X </searchLink><i>NLM ISO Abbreviation: </i>NPJ Precis Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40764401
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41698-025-01020-6
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 272
    Titles:
      – TitleFull: Inflammation and limited adaptive immunity predict worse outcomes on immunotherapy in head and neck cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Paschold L
      – PersonEntity:
          Name:
            NameFull: Schultheiss C
      – PersonEntity:
          Name:
            NameFull: Schmidt-Barbo P
      – PersonEntity:
          Name:
            NameFull: Klinghammer K
      – PersonEntity:
          Name:
            NameFull: Hahn D
      – PersonEntity:
          Name:
            NameFull: Tometten M
      – PersonEntity:
          Name:
            NameFull: Schafhausen P
      – PersonEntity:
          Name:
            NameFull: Blaurock M
      – PersonEntity:
          Name:
            NameFull: Brandt A
      – PersonEntity:
          Name:
            NameFull: Westgaard I
      – PersonEntity:
          Name:
            NameFull: Kowoll S
      – PersonEntity:
          Name:
            NameFull: Stein A
      – PersonEntity:
          Name:
            NameFull: Hinke A
      – PersonEntity:
          Name:
            NameFull: Binder M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 05
              M: 08
              Text: 2025 Aug 05
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 2397-768X
          Numbering:
            – Type: volume
              Value: 9
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: NPJ precision oncology
              Type: main
ResultId 1